These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8281327)

  • 1. Modifications in IgG subclasses in the course of immunotherapy with grass pollen.
    García BE; Sanz ML; Diéguez I; de las Marinas MD; Oehling A
    J Investig Allergol Clin Immunol; 1993; 3(1):19-25. PubMed ID: 8281327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
    Djurup R; Osterballe O
    Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific IgG subclasses in pollinosis.
    García BE; Sanz ML; Diéguez I; de las Marinas MD; Oehling A
    J Investig Allergol Clin Immunol; 1992; 2(6):300-6. PubMed ID: 1342913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies.
    Batard T; Basuyaux B; Laroze A; Lambin P; Brémard-Oury C; Aucouturier P; Hamilton RG; David B; Peltre G
    Int Arch Allergy Immunol; 1993; 102(3):279-87. PubMed ID: 8219781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.
    Roberts AM; Van Ree R; Cardy SM; Bevan LJ; Walker MR
    Immunology; 1992 Jul; 76(3):389-96. PubMed ID: 1526648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
    Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
    J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.
    van der Giessen M; Homan WL; van Kernbeek G; Aalberse RC; Dieges PH
    Int Arch Allergy Appl Immunol; 1976; 50(5):625-40. PubMed ID: 773842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE; Calderon M; Milani M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
    Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
    Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependence of immunological response to sublingual immunotherapy.
    Marcucci F; Sensi L; Di Cara G; Incorvaia C; Frati F
    Allergy; 2005 Jul; 60(7):952-6. PubMed ID: 15932387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.
    Malling HJ; Lund L; Ipsen H; Poulsen L
    J Investig Allergol Clin Immunol; 2006; 16(3):162-8. PubMed ID: 16784009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A; Henzgen M; Rajakulasingam K
    Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and clinical evaluation of a 12-month course of specific immunotherapy.
    Scordamaglia A; Pizzorno G; Caria M; Passalacqua G; Ruffoni S; Ciprandi G; Canonica GW
    Ann Allergy; 1989 Jul; 63(1):31-6. PubMed ID: 2742215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.
    Martínez-Cócera C; Sastre J; Cimarra M; Quirce S; Fernández-Rivas M; Enríquez-Matas A; Rodríguez-Alvarez M; Martín S
    J Investig Allergol Clin Immunol; 2010; 20(1):13-9. PubMed ID: 20232769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.